AleksandrLombrozo

Cleveland BioLabs is at the bottom of the weekly box

Alış
NASDAQ:CBLI   None
Despite reporting $1.9 million net loss for the second quarter of 2016 technical analysis stipulates the shares of the company would at least double its value.
The point is that there was a bullish engulfing at the bottom of a significant rectangle which lasts more than a year. Moreover RSI(5) analysis implies divergence which coupled with double bottom increases the chances a winning trade.
For more ideas visit mercurius.wordpress.com

Feragatname

Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.